Scientists will use $1 million from the National Multiple Sclerosis Society to explore ways to stop astrocytes from damaging ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Three UK patients have received “groundbreaking” treatment for the disease lupus, which could end their need for lifelong ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have ... with an initial rollout expected for phase 3 tests of ...

The new indictment adds three killings — including two in Nassau County — to others charges lodged against the gang members, ...

The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...